Caseware UK (AP4) 2023.0.135 2023.0.135 true2022-11-01falseNo description of principal activity1617trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09144815 2022-11-01 2023-10-31 09144815 2023-10-31 09144815 2021-11-01 2022-10-31 09144815 2022-10-31 09144815 c:Director1 2022-11-01 2023-10-31 09144815 d:Buildings d:LongLeaseholdAssets 2022-11-01 2023-10-31 09144815 d:Buildings d:LongLeaseholdAssets 2023-10-31 09144815 d:Buildings d:LongLeaseholdAssets 2022-10-31 09144815 d:PlantMachinery 2022-11-01 2023-10-31 09144815 d:PlantMachinery 2023-10-31 09144815 d:PlantMachinery 2022-10-31 09144815 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-11-01 2023-10-31 09144815 d:MotorVehicles 2022-11-01 2023-10-31 09144815 d:MotorVehicles 2023-10-31 09144815 d:MotorVehicles 2022-10-31 09144815 d:MotorVehicles d:OwnedOrFreeholdAssets 2022-11-01 2023-10-31 09144815 d:FurnitureFittings 2022-11-01 2023-10-31 09144815 d:FurnitureFittings 2023-10-31 09144815 d:FurnitureFittings 2022-10-31 09144815 d:FurnitureFittings d:OwnedOrFreeholdAssets 2022-11-01 2023-10-31 09144815 d:OfficeEquipment 2022-11-01 2023-10-31 09144815 d:OfficeEquipment 2023-10-31 09144815 d:OfficeEquipment 2022-10-31 09144815 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-11-01 2023-10-31 09144815 d:OwnedOrFreeholdAssets 2022-11-01 2023-10-31 09144815 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-10-31 09144815 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2022-10-31 09144815 d:Goodwill 2022-11-01 2023-10-31 09144815 d:Goodwill 2023-10-31 09144815 d:Goodwill 2022-10-31 09144815 d:OtherResidualIntangibleAssets 2022-11-01 2023-10-31 09144815 d:CurrentFinancialInstruments 2023-10-31 09144815 d:CurrentFinancialInstruments 2022-10-31 09144815 d:Non-currentFinancialInstruments 2023-10-31 09144815 d:Non-currentFinancialInstruments 2022-10-31 09144815 d:CurrentFinancialInstruments d:WithinOneYear 2023-10-31 09144815 d:CurrentFinancialInstruments d:WithinOneYear 2022-10-31 09144815 d:Non-currentFinancialInstruments d:AfterOneYear 2023-10-31 09144815 d:Non-currentFinancialInstruments d:AfterOneYear 2022-10-31 09144815 d:ShareCapital 2023-10-31 09144815 d:ShareCapital 2022-10-31 09144815 d:RetainedEarningsAccumulatedLosses 2023-10-31 09144815 d:RetainedEarningsAccumulatedLosses 2022-10-31 09144815 c:FRS102 2022-11-01 2023-10-31 09144815 c:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 09144815 c:FullAccounts 2022-11-01 2023-10-31 09144815 c:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 09144815 d:Goodwill d:OwnedIntangibleAssets 2022-11-01 2023-10-31 09144815 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:OwnedIntangibleAssets 2022-11-01 2023-10-31 iso4217:GBP xbrli:pure
Registered number: 09144815













Evolve Dentistry Limited

Financial statements
Information for filing with the registrar

31 October 2023




 
Evolve Dentistry Limited


Balance sheet
At 31 October 2023

2023
2022
Note
£
£

Fixed assets
  

Intangible assets
 5 
336,682
368,338

Tangible assets
 6 
191,275
248,791

  
527,957
617,129

Current assets
  

Stocks
  
15,548
14,476

Debtors: amounts falling due within one year
 7 
123,481
106,199

Bank and cash balances
  
160,429
133,145

  
299,458
253,820

Creditors: amounts falling due within one year
 8 
(264,206)
(170,161)

Net current assets
  
 
 
35,252
 
 
83,659

Total assets less current liabilities
  
563,209
700,788

Creditors: amounts falling due after more than one year
 9 
(328,633)
(512,785)

Provisions for liabilities
  

Deferred tax
  
(36,129)
(41,087)

  
 
 
(36,129)
 
 
(41,087)

Net assets
  
198,447
146,916


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
198,347
146,816

Shareholders' funds
  
198,447
146,916


1

 
Evolve Dentistry Limited

    
Balance sheet (continued)
At 31 October 2023

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 9 April 2024.




C Gough
Director

Company registered number: 09144815.
The notes on pages 3 to 8 form part of these financial statements.

2

 
Evolve Dentistry Limited
 
 

Notes to the financial statements
Year ended 31 October 2023

1.


General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Evolve Dentistry, 24 Harbour Road, Portishead, Bristol, Avon, BS20 7AL.


2.


Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3.Accounting policies

 
3.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
3.2

Revenue

The turnover shown in the profit and loss account represents income received from private fees and capitation schemes during the period.

 
3.3

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3

 
Evolve Dentistry Limited
 

 
Notes to the financial statements
Year ended 31 October 2023

3.Accounting policies (continued)

 
3.4

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the statement of comprehensive income over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Goodwill
-
20
years
Website costs
-
10
years

 
3.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Long-term leasehold property
-
10%
straight line
Plant and machinery
-
20%
reducing balance
Motor vehicles
-
25%
reducing balance
Fixtures and fittings
-
25%
straight line
Office equipment
-
33%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

4

 
Evolve Dentistry Limited
 

 
Notes to the financial statements
Year ended 31 October 2023

3.Accounting policies (continued)

 
3.6

Provisions for liabilities

Provisions are made where an event has taken place that gives the company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the balance sheet.

 
3.7

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.


4.


Employees

The average monthly number of employees, including directors, during the year was 16 (2022 - 17).

5

 
Evolve Dentistry Limited
 
 

Notes to the financial statements
Year ended 31 October 2023

5.


Intangible assets




Website costs
Goodwill
Total

£
£
£



Cost


At 1 November 2022
15,200
602,725
617,925



At 31 October 2023

15,200
602,725
617,925



Amortisation


At 1 November 2022
8,499
241,088
249,587


Charge for the year
1,520
30,136
31,656



At 31 October 2023

10,019
271,224
281,243



Net book value



At 31 October 2023
5,181
331,501
336,682



At 31 October 2022
6,701
361,637
368,338



6

 
Evolve Dentistry Limited
 
 

Notes to the financial statements
Year ended 31 October 2023

6.


Tangible fixed assets





Long-term leasehold property
Plant and machinery
Motor vehicles
Fixtures and fittings
Office equipment
Total

£
£
£
£
£
£



Cost or valuation


At 1 November 2022
35,000
335,760
51,345
4,272
16,735
443,112


Additions
-
43,661
1,500
3,406
3,234
51,801


Disposals
-
(179,941)
-
(2,647)
(15,748)
(198,336)



At 31 October 2023

35,000
199,480
52,845
5,031
4,221
296,577



Depreciation


At 1 November 2022
-
167,910
12,836
2,093
11,482
194,321


Charge for the year
3,500
33,503
9,908
897
2,279
50,087


Disposals
-
(124,328)
-
(2,058)
(12,720)
(139,106)



At 31 October 2023

3,500
77,085
22,744
932
1,041
105,302



Net book value



At 31 October 2023
31,500
122,395
30,101
4,099
3,180
191,275



At 31 October 2022
35,000
167,850
38,509
2,179
5,253
248,791


7.


Debtors

2023
2022
£
£


Trade debtors
34,778
8,640

Other debtors
85,553
94,409

Prepayments and accrued income
3,150
3,150

123,481
106,199


7

 
Evolve Dentistry Limited
 
 

Notes to the financial statements
Year ended 31 October 2023

8.


Creditors: amounts falling due within one year

2023
2022
£
£

Bank loans
54,659
66,905

Trade creditors
54,108
34,695

Corporation tax
34,440
-

Other taxation and social security
7,994
8,288

Obligations under finance lease and hire purchase contracts
27,173
44,970

Other creditors
1,908
1,524

Accruals and deferred income
83,924
13,779

264,206
170,161



9.


Creditors: amounts falling due after more than one year

2023
2022
£
£

Bank loans
177,096
271,421

Net obligations under finance leases and hire purchase contracts
24,204
73,431

Other creditors
127,333
167,933

328,633
512,785


 
8